Records containing: Neuroendocrine Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-06-05Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors
-
CLINICAL_TRIALS study record update · 2025-05-31A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-05-3061Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors: The COPPER PET in NET Study A Prospective, Open-label, Randomized, Controlled, Single Centre, Phase I/II PET/CT Study
-
CLINICAL_TRIALS study record update · 2025-05-21Value of Automatically Segmented Three-Dimensional(3D) Volumetric Body Composition in Predicting the Pathological Grading and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
-
CLINICAL_TRIALS study record update · 2025-05-20Lipiodol Deposition in Hypervascular Tumors: Endhole vs. Pressure-modulated Delivery
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-15Correlation Between SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-05-14A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours
-
CLINICAL_TRIALS study record update · 2025-05-11Randomized Open Label Study to Compare the Efficacy and Safety of Everolimus Followed by Chemotherapy With Streptozotocin- Fluorouracilo (STZ-5FU) Upon Progression or the Reverse Sequence, in Advanced Progressive Pancreatic NETs (pNETs)
-
CLINICAL_TRIALS study record update · 2025-05-09A Pilot Study To Evaluate Patient Experience With the Somatostatin Analogs Octreotide Long Acting Release and Lanreotide During the Treatment of Advanced, Nonfunctional, Well Differentiated Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-05-08An Open-Label Phase Ib/II Study of Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-05-0768Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
-
CLINICAL_TRIALS study record update · 2025-05-07EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
-
CLINICAL_TRIALS study record update · 2025-05-02A Pilot Study Investigating Intrahepatic Arterial And Intravenous Infusion Of The Radiolabeled Somatostatin Agonist 177Lu-DOTATATE In Patients With Liver-Dominant Metastatic Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Well Differentiated Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-05-02Iconographic Registry of Pancreatobiliary Endoscopy Procedures
-
CLINICAL_TRIALS study record update · 2025-05-01Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues for the Imaging of Neuroendocrine Tumours.
-
CLINICAL_TRIALS study record update · 2025-04-27An Open-Label, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 in Combination With Toripalimab/ Tislelizumab in Patients With Advanced NEN and Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-04-22Clinical Application of a Novel 18F Labeled Fibroblast Activation Protein (FAP) Targeted Molecular Probe in Early Tumor Diagnosis
-
CLINICAL_TRIALS study record update · 2025-04-17A Phase IB Study of Safety, Efficacy and Pharmacokinetic of Intravenously Administered Pelcitoclax (APG-1252) in Patients With Advanced Neuroendocrine Tumor
-
CLINICAL_TRIALS study record update · 2025-04-03Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN. REBORN Study
-
CLINICAL_TRIALS study record update · 2025-04-02Evaluation of Biodistribution, Dosimetry, Diagnostic Ability, and Safety of Al18F-NOTA-LM3 in Patients With Well-differentiated Neuroendocrine Tumors, and Comparison With 68Ga-DOTATATE and 68Ga-NODAGA-LM3: A Prospective, Single-center, Double-blinded Study
-
CLINICAL_TRIALS study record update · 2025-03-30Dosing of Various Multi Kinases Inhibitors Plasma Concentrations for Patients Treated for Their Advanced Digestive Cancer, With the Aim to Determine the Best Optimal Dose for Each Treatment, in the Future
-
CLINICAL_TRIALS study record update · 2025-03-27The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
-
CLINICAL_TRIALS study record update · 2025-03-19A Phase I/IIA Study of 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
-
CLINICAL_TRIALS study record update · 2025-03-17A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
-
CLINICAL_TRIALS study record update · 2025-03-03Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial